Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Holmberg

Showing results (271-280 of 287) with videos related to

Pageof 29
Sort By:
Scandinavian Journal of Urology and Nephrology|October 16, 2007
Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005Jan Adolfsson, Hans Garmo, Eberhard Varenhorst, et al.
Breast Cancer Research : BCR|October 15, 2017
Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread: a case control studyKatherine Lawler, Efterpi Papouli, Cristina Naceur-Lombardelli, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 18, 2008
Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohortLorelei A Mucci, Yudi Pawitan, Francesca Demichelis, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 28, 2008
Testing a multigene signature of prostate cancer death in the Swedish Watchful Waiting CohortLorelei A Mucci, Yudi Pawitan, Francesca Demichelis, et al.
Breast Cancer Research : BCR|November 11, 2005
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohortsYudi Pawitan, Judith Bjöhle, Lukas Amler, et al.
Blood|January 31, 2008
Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWDGiancarlo Castaman, Stefan Lethagen, Augusto B Federici, et al.
Blood|March 18, 2008
Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD)Sandra L Haberichter, Giancarlo Castaman, Ulrich Budde, et al.
BJU International|January 23, 2016
Prostate-specific antigen patterns in US and European populations: comparison of six diverse cohortsAndrew J Simpkin, Jenny L Donovan, Kate Tilling, et al.
Radiology|March 2, 2021
Beneficial Effect of Consecutive Screening Mammography Examinations on Mortality from Breast Cancer: A Prospective StudyStephen W Duffy, László Tabár, Amy Ming-Fang Yen, et al.
Blood|September 21, 2006
Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)Anne Goodeve, Jeroen Eikenboom, Giancarlo Castaman, et al.
Pageof 29

Showing results (271-280 of 287) with videos related to

Sort By:
Pageof 29
Scandinavian Journal of Urology and Nephrology|October 16, 2007
Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005Jan Adolfsson, Hans Garmo, Eberhard Varenhorst, et al.
Breast Cancer Research : BCR|October 15, 2017
Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread: a case control studyKatherine Lawler, Efterpi Papouli, Cristina Naceur-Lombardelli, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 18, 2008
Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohortLorelei A Mucci, Yudi Pawitan, Francesca Demichelis, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 28, 2008
Testing a multigene signature of prostate cancer death in the Swedish Watchful Waiting CohortLorelei A Mucci, Yudi Pawitan, Francesca Demichelis, et al.
Breast Cancer Research : BCR|November 11, 2005
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohortsYudi Pawitan, Judith Bjöhle, Lukas Amler, et al.
Blood|January 31, 2008
Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWDGiancarlo Castaman, Stefan Lethagen, Augusto B Federici, et al.
Blood|March 18, 2008
Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD)Sandra L Haberichter, Giancarlo Castaman, Ulrich Budde, et al.
BJU International|January 23, 2016
Prostate-specific antigen patterns in US and European populations: comparison of six diverse cohortsAndrew J Simpkin, Jenny L Donovan, Kate Tilling, et al.
Radiology|March 2, 2021
Beneficial Effect of Consecutive Screening Mammography Examinations on Mortality from Breast Cancer: A Prospective StudyStephen W Duffy, László Tabár, Amy Ming-Fang Yen, et al.
Blood|September 21, 2006
Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)Anne Goodeve, Jeroen Eikenboom, Giancarlo Castaman, et al.
Pageof 29